Polaris Group clinical trials we track

Check company identity source

Phase 3 2 trials

Phase 2 / 3 1 trial

TrialDrugs studiedStatusPrimary completion
Ph 2/3 Study in Subjects With MPM to Assess ADI-PEG 20 With Pemetrexed and CisplatinNCT02709512ADI-PEG 20 plus Pem PlatinumCompleted2022-08-15Actual

Phase 2 2 trials

TrialDrugs studiedStatusPrimary completion
Study of ADI-PEG 20 Versus Placebo in Subjects With NASHNCT05842512ADI-PEG20Recruiting2027-12-31Estimated
ADI-PEG 20 Plus Radiotherapy and Temozolomide in Subjects With Glioblastoma MultiformeNCT04587830ADI-PEG 20, TemozolomideActive not recruiting2027-02-28Estimated

Drugs in these trials

Names as written in the registry records.

Latest recorded trial changes

Filters
Clear filters

· 5 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 300 participants (planned). After: 218 participants (actual).

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: 30 Dec 2027. After: 25 May 2026.

Recruitment status changed

Before: Recruiting. After: Terminated.

Check registry source